IRONWOOD PHARMACEUTICALS, INC.
BOSTON, MA

Ironwood Pharmaceuticals, Inc., founded on April 29, 2012, is a pharmaceutical company headquartered in Boston, Massachusetts. With its official website at ironwoodpharmaceuticals.com, Ironwood operates under the status Florida.Models.Dos.FloridaCompanyStatus in Broward County and has filed the number F12000001838 with a filing state of Delaware (DE). The company primarily functions as a For-Profit Corporation (FORP) and follows an ethos deeply rooted in advancing scientific and artistic innovation to develop medicines that significantly improve patient lives. Ironwood's name is inspired by the ironwood tree, symbolizing resilience and endurance, reflecting the company’s commitment to creating a robust pharmaceutical presence with products that offer substantial value over time. This metaphor captures the firm's dual focus on science's rigidity (iron) and its flexibility in application (wood), representing a blend of scientific rigor and artistic design in their medicinal offerings. The mission statement emphasizes being more than just shareholders but active owners with vested interests, urging engagement through a transparent communication policy about business challenges, opportunities, and strategic decisions. Its leadership includes Julie H McHugh as Chair of the Board, along with Directors Andrew Dreyfus and Mark Currie who guide the company's strategic direction. Ironwood Pharmaceuticals is dedicated to addressing complex therapeutic needs, including hypersensitivity management related to allopurinol byproducts like DUZALLO. The company has expressed caution in instances where adverse reactions can occur, particularly when co-administered with certain medications such as thiazide diuretics or amongst patients with renal impairment. The firm's contact options include various phone numbers: (617) 621-7722, (617) 494-0480, and a toll-free line at (844) 374-4793. The latest annual report was filed on April 13, 2024, confirming continuous compliance and regulatory oversight. The company’s commitment to advancing healthcare through innovative drug development underscores its philosophy: the art and science of making medicines that offer relief and improved quality of life for patients globally.